Patient P-02037
Therapy response
Stable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Stable
Discontinuation risk
20%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S04
- Day 16 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 22 GI-04 recommended — GI Support Protocol GI-04
- Day 23 Patient accepted — Started GI-04 in the companion
- Day 31 GI symptom burden −11% vs expected — GI Support Protocol GI-04
- Day 37 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 16.
Primary contributors, last 14 days
- GI instability+4
- Inflammatory activity-4
- Nutritional resilience+4
- Treatment adherence+4
- Toxicity-4
What helped?
- GI Support Protocol GI-04Day 22Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓70
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 5.5 h, below personal baseline
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 30/100
- Autonomic recovery ↑20
- WearableShort sleep window
- Inflammatory signalling ↓15
- WearableHRV 32 ms, trending down
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.1 · butyrate capacity 30/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 31 ms
- Sleep
- 6.6 h
- Steps
- 8,972
- Resting HR
- 70 bpm
Daily log: GI score 23, nutritional resilience 59, adherence 96.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02538 | 53% | S02 | GI-04 | improved | 59 |
| P-02033 | 52% | S06 | GI-04 | improved | 51 |
| P-02058 | 52% | S05 | GI-04 | no change | 48 |
| P-02305 | 52% | S20 | — | — | 46 |
| P-02351 | 52% | S16 | — | — | 51 |
| P-02513 | 51% | S16 | GI-04 | no change | 46 |
| P-02158 | 50% | S20 | — | — | 43 |
| P-02219 | 50% | S13 | — | — | 60 |
| P-02339 | 50% | S03 | DT-01 | improved | 50 |
| P-02639 | 50% | S08 | — | — | 58 |
| P-02235 | 49% | S14 | DT-01 | improved | 50 |
| P-02262 | 49% | S16 | — | — | 53 |